2seventy bio, Inc. announced that Chip Baird, formerly Chief Financial Officer, is now Chief Operating Officer expanding his responsibilities to include finance, corporate development, investor relations and corporate communications as well as portfolio and program/alliance management. The company announced that on September 11, 2023, Nick Leschly, the Company?s president and chief executive officer, notified the Company?s board of directors of his intent to resign as president and chief executive officer upon the Board?s identification of his successor. On September 10, 2023, the board of directors of the Company appointed William D. Baird, III as the chief operating officer of the Company.

Mr. Baird will continue to serve as the Company?s principal financial officer and principal accounting officer. Mr. Baird, 52, has served as the Company?s chief financial officer since 2021. Previously, Mr. Baird served as chief financial officer of bluebird bio, Inc. from February 2019 until November 2021 and served as chief financial officer of Amicus Therapeutics, Inc. from April 2012 until February 2019.

Mr. Baird has served on the board of directors of Axcella Health Inc. since June 2018.